Edwards buys Embrella for $43M

Justine Varieur Cadet | | Health Imaging | Enterprise Imaging
Edwards Lifesciences has acquired Embrella Cardiovascular, the developer of the Embrella Embolic Deflector System that can be used during transcatheter heart valve procedures, for a purchase price of approximately $43 million in cash.

The single-use, disposable Embrella device is placed in the aorta through a sheath inserted in the right brachial or right radial artery. The company said its porous membrane allows blood flow to the brain while simultaneously deflecting embolic material. The Embrella Embolic Deflector System has been assessed in a limited clinical study in Europe and received CE mark in May 2010.

Additionally, the Irvine, Calif.-based Edwards said it is maintaining its earnings guidance for the year.

Justine Varieur Cadet

Related Content

Less than half of incidental interstitial lung abnormalities on CT exams are reported
Are providers too trusting of AI's advice?
Pairing an alert system with CAD software halves time-to-treatment for pneumothorax
Patients without PCPs struggle to access lung cancer screening, despite eligibility
Rads are more accurate when they have access to patients' self-reported symptoms
AI-based software improves follow-up imaging adherence by 74%

Around the web

Cardiovascular Business
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.